Full name
LIBER APTEKI SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.19.Z - Retail trade
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
52.10.B - Warehousing and storage of other goods
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0,2 | -0,2 | -16 | |
Gross profit (loss) | 0,1 | -0 | -0,3 | -4973,6 |
EBITDA | -0,2 | -0,2 | -7,5 | |
Short time liabilities | 5,7 | 6,1 | 7,8 | |
Income tax | 0 | |||
Other operating costs | 0 | 0 | -48,5 | |
Equity capital | -4,2 | -4,2 | -4,5 | -7,4 |
Operating profit (EBIT) | -0,2 | -0,3 | -4,6 | |
Assets | 1,5 | 1,5 | 1,6 | 9,4 |
Net profit (loss) | 0,1 | -0 | -0,3 | -4832,8 |
Cash | 0 | 0 | 13,9 | |
Liabilities and provisions for liabilities | 5,6 | 5,7 | 6,1 | 7,9 |
Net income from sale | 2,9 | 3,1 | 7 | |
Working assets | 0,4 | 0,5 | 0,6 | 33,6 |
Other income costs | 0 | 0 | 116 715,9 | |
Basic operational activity income | 2,5 | |||
Depreciation | 0 | 0 | -11,7 | |
% | % | % | p.p. | |
Profitability of capital | 0,1 | 6,9 | 6,8 | |
Equity capital to total assets | -286,4 | -277,5 | -272,6 | 4,9 |
Gross profit margin | 5,8 | -0,2 | -10 | -9,8 |
EBITDA Margin | -7,3 | -7,3 | 0 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 718 | 724 | 6 | |
Current financial liquidity indicator | 0.08443276584148407 | 0.10465313494205475 | 0 | |
Net dept to EBITDA | 0.034876905381679535 | 0.036956243216991425 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane